CORAL GABLES, Fla., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback